Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the research gaps as outlined in the specific RFP.
Research projects that will be considered for Pfizer support will advance the medical knowledge of short stature.
Research Projects submitted may include: •Diagnostics, early treatment, new treatment paradigms •Clinical outcomes, quality of life, and patient reported outcomes •Medication adherence research including innovative methods to evaluate levels of adherence of growth hormone treatment •Translational or clinical research
Grant Application due date: June 30, 2022
Geographic Scope: United States
•The institution and principal investigator (PI) must be based in one of the eligible countries noted above. •Only organizations are eligible to receive grants, not individuals or medical practice groups. •The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work. •Applicant must be affiliated with a host institution
Individual projects requesting up to $100,000 will be considered. Pfizer anticipates awarding 1 grant.
